EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
17hon MSN
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
The cancer vaccine market is anticipated to experience substantial growth in the coming years. This growth is driven by the rising number of cancer diagnoses, heightened awareness of cancer vaccines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results